RESUMO
The objective of the study was to evaluate the epidemiology of patients with congenital myasthenic syndrome (CMS) in Israel. Targeted mutation analysis was performed based on the clinical symptoms and electrophysiological findings for known CMS. Additional specific tests were performed in patients of Iranian and/or Iraqi Jewish origin. All medical records were reviewed and clinical data, genetic mutations and outcomes were recorded. Forty-five patients with genetic mutations in known CMS genes from 35 families were identified. Mutations in RAPSN were identified in 13 kinships in Israel. The most common mutation was c.-38A>G detected in 8 patients of Iranian and/or Iraqi Jewish origin. Four different recessive mutations in COLQ were identified in 11 kinships, 10 of which were of Muslim-Arab descent. Mutations in CHRNE were identified in 7 kinships. Less commonly detected mutations were in CHRND, CHAT, GFPT1 and DOK7. In conclusion, mutations in RAPSN and COLQ are the most common causes of CMS in our cohort. Specific mutations in COLQ, RAPSN, and CHRNE occur in specific ethnic populations and should be taken into account when the diagnosis of a CMS is suspected.
Assuntos
Acetilcolinesterase/genética , Colágeno/genética , Proteínas Musculares/genética , Síndromes Miastênicas Congênitas/etnologia , Síndromes Miastênicas Congênitas/genética , Receptores Nicotínicos/genética , Análise Mutacional de DNA , Humanos , Irã (Geográfico)/etnologia , Iraque/etnologia , Israel/etnologia , LinhagemAssuntos
Doenças Neuromusculares/etnologia , Roma (Grupo Étnico)/genética , Bulgária/epidemiologia , Congressos como Assunto , Consanguinidade , Cultura , Etnicidade/genética , Efeito Fundador , França/epidemiologia , História do Século XV , História do Século XIX , História do Século XX , História Antiga , História Medieval , Humanos , Índia/etnologia , Idioma , Complexos Multienzimáticos/genética , Síndromes Miastênicas Congênitas/etnologia , Síndromes Miastênicas Congênitas/genética , Doenças Neuromusculares/genética , Paquistão/etnologia , Roma (Grupo Étnico)/históriaRESUMO
Congenital myasthenic syndromes (CMS) are caused by mutations in genes expressed at the neuromuscular junction. Most CMS patients have been reported in Western and Middle Eastern countries, and only four patients with COLQ mutations have been reported in Japan. We here report six mutations in acetylcholine receptor (AChR) subunit genes in five Japanese patients. Five mutations are novel, and one mutation is shared with a European American patient but with a different haplotype. Among the observed mutations, p.Thr284Pro (p.Thr264Pro according to the legacy annotation) in the epsilon subunit causes a slow-channel CMS. Five other mutations in the delta and epsilon subunits are splice site, frameshift, null, or missense mutations causing endplate AChR deficiency. We also found a heteroallelic p.Met465Thr in the beta subunit in another patient. p.Met465Thr, however, was likely to be polymorphism, because single channel recordings showed mild shortening of channel openings without affecting cell surface expression of AChR, and the minor allelic frequency of p.Met465Thr was 5.1% in the Japanese population. Lack of shared mutant alleles between the Japanese and the other patients suggests that most mutations described here are ethnically unique or de novo in each family.
Assuntos
Mutação , Síndromes Miastênicas Congênitas/etnologia , Síndromes Miastênicas Congênitas/genética , Subunidades Proteicas/genética , Receptores Nicotínicos/genética , Adolescente , Adulto , Criança , Feminino , Células HEK293 , Humanos , Japão/etnologia , Masculino , Músculo Esquelético/metabolismo , Linhagem , Polimorfismo de Nucleotídeo Único , Receptores Nicotínicos/fisiologia , Adulto JovemRESUMO
Congenital myasthenic syndrome shows a wide clinical heterogeneity. However, the unusual pattern of muscle weakness and the presence of variable degree of muscle pathology, subtle electrophysiological abnormalities and lack of circadian variability of symptoms may complicate its recognition. We have previously reported a Palestinian family with suspected congenital muscular dystrophy and linkage to chromosome 4p16.3. As the DOK7 gene is located in this genetic interval, we considered it a potential candidate for this condition. Patients showed a homozygous DOK7 pathogenic mutation (c.957delC). We have re-examined six patients and found permanent limb-girdle weakness, but also episodic crises without clear precipitating factors. Following the revised diagnosis, patients were treated with salbutamol for 8 months with significant improvement in their muscle strength and function. This family needs to be reclassified as congenital myasthenic syndrome rather than congenital muscular dystrophy.
Assuntos
Proteínas Musculares/genética , Distrofia Muscular do Cíngulo dos Membros/congênito , Distrofia Muscular do Cíngulo dos Membros/genética , Mutação/genética , Síndromes Miastênicas Congênitas/genética , Agonistas de Receptores Adrenérgicos beta 2/farmacologia , Adulto , Albuterol/farmacologia , Diagnóstico Diferencial , Efedrina/farmacologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Força Muscular/efeitos dos fármacos , Força Muscular/fisiologia , Debilidade Muscular/genética , Debilidade Muscular/fisiopatologia , Distrofia Muscular do Cíngulo dos Membros/diagnóstico , Síndromes Miastênicas Congênitas/diagnóstico , Síndromes Miastênicas Congênitas/etnologia , Paquistão , Resultado do TratamentoRESUMO
We describe the clinical characteristics of 3 siblings from 1 family with congenital myasthenic syndrome due to homozygous mutations of the gene coding for the epsilon subunit of the acetylcholine receptor (CHRNE). Onset of symptoms occurred in the first few months of life with ptosis, restricted ocular motility, mild proximal weakness, and difficulty swallowing. Multiple hospital admissions were required due to recurrent pulmonary infections. There was no decremental conduction on repetitive nerve stimulation, but jitter was increased on single fiber electromyographic. Since early childhood, our patients have done well without pulmonary or bulbar symptoms and with partial improvement on pyridostigmine therapy. Response of ptosis to diagnostic ice pack test was striking. Although these siblings have a clinical history and examination findings typical of homozygous CHRNE mutations, the clinical presentation of congenital myasthenia subtypes is variable, and accurate genotyping is essential in choosing the appropriate treatment.
Assuntos
Predisposição Genética para Doença/genética , Homozigoto , Mutação/genética , Síndromes Miastênicas Congênitas/genética , Receptores Nicotínicos/genética , Adolescente , Humanos , Masculino , Síndromes Miastênicas Congênitas/etnologia , Brometo de Piridostigmina/uso terapêutico , Arábia Saudita/etnologia , Irmãos , Resultado do Tratamento , Adulto JovemRESUMO
OBJECTIVE: Mutations in various genes of the neuromuscular junction cause congenital myasthenic syndrome (CMS). A single truncating mutation (epsilon1293insG) in the acetylcholine receptor epsilon subunit gene (CHRNE) was most often identified in CMS families originating from North Africa and was possibly a founder mutation. METHODS: Twenty-three families were studied with an early onset form of CMS and originating from Tunisia, Algeria, Morocco, and Libya. Screening for the mutation epsilon1293insG was performed by direct sequencing. Haplotype analysis was done with 9 (CA)n repeat microsatellite markers and 6 SNPs flanking epsilon1293insG on chromosome 17p13-p12. Dating was calculated using the ESTIAGE method for rare genetic diseases. RESULTS: The epsilon1293insG mutation was identified in 14 families (about 60% of the initial 23). The expression of the CMS in affected members of these families was relatively homogeneous, without fetal involvement or being life-threatening, with moderate hypotonia and oculobulbar involvement, mild and stable disease course, and good response to cholinesterase inhibitors. Haplotype analysis revealed a common conserved haplotype encompassing a distance of 63 kb. The estimated age of the founder event was at least 700 years. CONCLUSIONS: These results strongly support the hypothesis that epsilon1293insG derives from an ancient single founder event in the North African population. Identification of founder mutations in isolated or inbred populations may have important implications in the context of molecular diagnosis and genetic counseling of patients and families by detection of heterozygous carriers.
Assuntos
Predisposição Genética para Doença/genética , Mutação/genética , Síndromes Miastênicas Congênitas/genética , Receptores Nicotínicos/genética , África do Norte/etnologia , Inibidores da Colinesterase/farmacologia , Análise Mutacional de DNA , Feminino , Efeito Fundador , Frequência do Gene , Aconselhamento Genético/normas , Marcadores Genéticos/genética , Testes Genéticos , Genótipo , Haplótipos , Heterozigoto , Humanos , Masculino , Biologia Molecular/normas , Síndromes Miastênicas Congênitas/etnologia , Síndromes Miastênicas Congênitas/fisiopatologiaRESUMO
Emery-Dreifuss muscular dystrophy (EDMD) is an X-linked humero-peroneal muscular dystrophy associated with contractures and cardiomyopathy. In a 90 member family, we found 11 affected male individuals, three of whom displayed areflexia and neurogenic electromyographic changes. Muscle biopsy performed in one case demonstrated type grouping suggestive of a neurogenic disorder. These three individuals and another family member, who suffers from mild, static limb weakness but is clinically and genetically unaffected by EDMD showed an abnormal incremental response of over 100% to tetanic stimulation. In contrast, one affected family member showed myopathic features on needle electromyography and no definite pathology in repetitive stimulation studies. The diagnosis of EDMD was established by demonstrating a 1712_1713insTGGGC mutation in the emerin gene. This family apparently expresses co-morbidity of EDMD with an exceptionally mild form of pre-synaptic congenital myasthenic syndrome resembling the Lambert-Eaton myasthenic syndrome (LEMS). The superimposed pre-synaptic disorder may have contributed to the development of the neurogenic features demonstrated in these patients.
Assuntos
Predisposição Genética para Doença/genética , Músculo Esquelético/fisiopatologia , Distrofia Muscular de Emery-Dreifuss/etnologia , Distrofia Muscular de Emery-Dreifuss/fisiopatologia , Síndromes Miastênicas Congênitas/etnologia , Síndromes Miastênicas Congênitas/fisiopatologia , Adolescente , Adulto , Árabes/genética , Criança , Pré-Escolar , Comorbidade , Análise Mutacional de DNA , Progressão da Doença , Feminino , Doenças Genéticas Ligadas ao Cromossomo X/etnologia , Doenças Genéticas Ligadas ao Cromossomo X/genética , Doenças Genéticas Ligadas ao Cromossomo X/fisiopatologia , Ligação Genética/genética , Testes Genéticos , Genótipo , Humanos , Masculino , Proteínas de Membrana/genética , Pessoa de Meia-Idade , Músculo Esquelético/inervação , Músculo Esquelético/patologia , Distrofia Muscular de Emery-Dreifuss/genética , Síndromes Miastênicas Congênitas/genética , Proteínas Nucleares/genética , Linhagem , FenótipoRESUMO
OBJECTIVE: Mutation analysis of the acetylcholine receptor (AChR) epsilon subunit gene in patients with sporadic or autosomal recessive congenital myasthenic syndromes (CMS). BACKGROUND: The nicotinic AChR of skeletal muscle is a neurotransmitter-gated ion channel that mediates synaptic transmission at the vertebrate neuromuscular junction. Mutations in its gene may cause congenital myasthenic syndromes. A recently described mutation in exon 12 of the AChR epsilon subunit (epsilon1267delG) disrupts the cytoplasmic loop and the fourth transmembrane region (M4) of the AChR epsilon subunit. METHODS: Forty-three CMS patients from 35 nonrelated families were clinically classified as sporadic cases of CMS (group III according to European Neuromuscular Centre consensus) and were analyzed for epsilon1267delG by PCR amplification and sequence analysis. RESULTS: The authors report the complete genomic sequence and organization of the gene coding for the epsilon subunit of the human AChR (accession number AF105999). Homozygous epsilon1267delG was identified in 13 CMS patients from 11 independent families. All epsilon1267delG families were of Gypsy or southeastern European origin. Genotype analysis indicated that they derive from a common ancestor (founder) causing CMS in the southeastern European Gypsy population. Phenotype analysis revealed a uniform pattern of clinical features including bilateral ptosis and mild to moderate fatigable weakness of ocular, facial, bulbar, and limb muscles. CONCLUSIONS: The mutation epsilon1267delG might be frequent in European congenital myasthenic syndrome patients of Gypsy ethnic origin. In general, patients (epsilon1267delG) were characterized by the onset of symptoms in early infancy, the presence of ophthalmoparesis, positive response to anticholinesterase treatment, and the benign natural course of the disease.